Get Full access to Top 1000 data, subscribe from only €29

Register Now »
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data


By Turnover

(€491.6 million)

By Employees

159th in Top Companies By Turnover
  • 300
  • €491.6 million


  • Michael O’Donnell CEO/Managing Director

Latest News


Thanks, You are now signed up to the Top 1000 newsletter!